Dr. Aysegul Kargi Chat

- Best Poster First Prize-Yalcin AD, Gorczynski RM, Bright GE, Kargi A, Bisgin A, Sahin E, Kose S, Gumuslu S. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide in patients with severe persistent allergic asthma: its relationship to omalizumab treatment. Clin Lab. 2012; 58 (1-2): 89-96 - Best Poster Award- MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer. Dogu GG, Kargi A, Turgut S, Ayada C, Taskoyl BY, Demiray G, Yaren A, Ozlu C, Temel S, Ergin A. Gene. 2012 Sep 15; 506 (2): 404-7. Doi: 10.1016 / j.gene.2012.06.057. Epub 2012 Jul 2 - Best Poster Paper Second Prize- Lymphoma, Myeloma and pesticide Usage. M. Yildirim, A. Kargı, UD Dilli, M. Yildiz, AD Yalçinkaya, E. Kurtoglu, H. Karakilinc. 10-13 May 2012.

• Associated with research and published papers in noted medical journals. These are: 
• Articles published in international refereed journals:
• A1. Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM, "IL-8 and Serum Soluble TRAIL Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients with Metastatic Colon Cancer", Clin Lab. (ISI), 501-505 pp., 2012, DOI: PMID: 22783581
• A2. Dogu GG, Kargi A, Turgut S, Ayada C, Taskoylu BY, Demiray G, Yaren A, Ozlu C, Temel S, Ergin A., "MDR 1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer" , Gene (ISI), 404-7 pp., 2012, DOI: 10.1016 / j.gene.2012.06.057
• A3. Bisgin A, Kargi A, Yalcin AD, Aydin C, Ekinci D, Savas B, Sanlioglu S, "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer", BMC Cancer (ISI), 58-63 pp. , 2012, DOI: 10.1186 / 1471-2407-12-58
• A4. Yalcin AD, Bisgin A, Kargi A, Gorczynski RM, "Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment", Med Sci Monit. (ISI), 11-15 pp., 2012, DOI: 2012 Mar; 18 (3): PI11-5.
• A5. Yalcin AD, Gorczynski RM, Bright GE, Kargi A, Bisgin A, Sahin E, Kose S, Gumuslu S., "Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment ", Clin Lab. (ISI), 89-96 pp., 2012, DOI: PMID: 22372350
• A6. Yalcin AD, Gumuslu S, Bright GE, Bisgin A, Yildiz M, Kargi A, Gorczynski RM, "Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis", Immunopharmacol Immunotoxicol. (ISI), 1-7 pp., 2012, DOI: 10.3109 / 08923973.2012.697902
• A7. AD Yalçin, A. Kargi, B. Savas, RM Gorczynski, "Interaction of Allergic Disease and (Immune) Response to Cancer in", Clin. Lab. (ISI), 58 pp., 2012, DOI: 10.7754 / Clin.Lab.2012.120321
• A8. Kargi A, Demirpence O, Gunduz S, Goktas S, Alikanoglu AS, Yildirim M. Serum levels of HMG1 has a diagnostic role in metastatic renal cell cancer. Cancer Biomark, 2016 Apr 1; 17 (1): 17-20.doi: 10.3233 / CBM-160611.
• A9. Yilmaz S, Ozdogan M, Cevener M, Ozluk A, Kargi A, Kendiroglu F, Teacher I, Yildiz A. Use of cryoablation beyond the prostate. Insights Imaging 2016Apr; 7 (2): 223-32.Doi: 10.1007 / s13244-015-0460-7.Epub 2016 Jan 13. Review
• A10. Mutlu H, Musri FY, Artac M, Kargi A, Ozdogan M, Bozcuk H, Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer. J Cancer Res Ther 2015 Apr Jub; 11 (2) 287-90, Doi: 10.4103 / 0973-1482.154008
• A11. Arslan D, Tural D, Koca T, Tastekin D, Kaymak Cerkesli A, Basaran H, Gunduz S, Murat Tatli A, Sezgin Goksu S, Uysal M, Kargi A, Kargi B, Koral L, Ibrahim Bassorgun C, Unal D, Mutlu H, Senol Coskun H, Ozdogan M, Bozcuk H. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer. J BUON, 2015 Mar-Apr; 20 (2): 573-9.
• A12. Uysal M, Ozdogan M, Kargi A, Gunduz S, Sezgin Goksu S, Murat Tatli A, Arslan D, Mutlu H, Senol Coskun H, Bozcuk H. Prolonged progression-free survival with metronomic oral cyclophosphamide and Etoposide treatment in macroscopic J BUON. 2014 Oct-Dec; 19 (4): 980-4.